Sort
21,453 grants matching “tuberculosis”
SUNY AIDS INTERNATIONAL TRAINING PROGRAM
$478,600Suny Downstate Medical Center · D43 · FY2002 · TW
CD4 T Cells in Tuberculosis
$478,541University Of Pittsburgh At Pittsburgh · R01 · FY2004 · AI
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeutic nanoparticles for TB
$478,506Jessica L Reynolds · State University Of New York At Buffalo · R01 · FY2019 · AI
Rapid in-field malaria diagnosis, prognosis and monitoring using a mobile phone
$478,505Peter B Lillehoj · Michigan State University · R01 · FY2015 · AI
IMPROVED DIAGNOSIS AND TREATMENT OF TUBERCULOSIS WITH EMPHASIS ON THE HOMELESS IN
$478,492Elizabeth Funk · Alaska State Department Of Hlth-Soc Svcs · U62 · FY2008 · PS
Purine Analog Anti-Mycobacterial Drug Development
$478,491William B Parker · Southern Research Institute · R01 · FY2006 · AI
Biochemistry of Energy-Dependent (Intracellular) Protein Degradation
$478,415Michael Maurizi · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy
$478,291William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Mali Project (Serefo)
$478,290Michael L. Polis · National Institute Of Allergy And Infectious Diseases · ZID · FY2010 · AI
Cell Biology of Mycobacterium tuberculosis Infection
$478,231Cornell University Ithaca · R01 · FY2005 · AI
Role of ribosome modulating proteins in conferring Mycobacterium abscessus antibiotic resistance
$478,217Pallavi Ghosh · Wadsworth Center · R01 · FY2023 · AI
Biomimetic Peptide Aerosols for Rapid Clearance of Pulmonary MDR Tuberculosis
$478,139Scott Hammond Medina · Pennsylvania State University, The · R01 · FY2024 · AI
Impact of TB on Outcome of HIV in Pregnant Women
$478,129Richard E Chaisson · Johns Hopkins University · R01 · FY2012 · HD
Metabolic determinants of barrier function in rifampin-sensitive and -resistant Mtb
$478,125Kyu Y Rhee · Brigham And Women'S Hospital · U19 · FY2023 · AI
Administrative Core
$478,096Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Development of an Oral Carbapenem Drug for Treatment of Drug Resistant TB
$478,053Gyanu Lamichhane · Johns Hopkins University · R33 · FY2017 · AI
Towards a generalizable drug discovery framework based on intrinsically disordered regions
$477,873Gil Alterovitz · Boston Children'S Hospital · R01 · FY2017 · GM
Towards a generalizable drug discovery framework based on intrinsically disordered regions
$477,840Gil Alterovitz · Boston Children'S Hospital · R01 · FY2016 · GM
Oxygen Activation and Radical Transfer in Ribonucleotide Reductase from Pathogens
$477,674Joseph M Bollinger · Pennsylvania State University, The · R01 · FY2009 · GM
CD8 T cell and B cell collaboration following subunit vaccination
$477,558Ross M Kedl · University Of Colorado Denver · R01 · FY2023 · AI
Project 2: Innate immune responses triggered by M. tuberculosis
$477,440Jeffery S Cox · University Of California Berkeley · P01 · FY2020 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$477,409William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2013 · AI
Understanding How the Ubiquitin Ligase CBL Regulates Innate Immune Responses
$477,394Bennett Penn · University Of California At Davis · R01 · FY2020 · AI
M. tuberculosis &host gene expression during infection
$477,308Public Health Research Institute · R01 · FY2005 · HL
Emerging XDR-TB: Host and Pathogen Contributions
$477,307Gilla Kaplan · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2012 · AI